Trump Warns That US May Use Defense Production Act To Ensure COVID-19 Vaccine Supply
President’s comments follow two revelations: Pfizer’s acknowledgement that it will not meet its previously-stated vaccine production goals for 2020, and the US government’s decide to pass on additional Pfizer doses which have since been allocated to other countries.
You may also be interested in...
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.
California attorney general Xavier Becerra has sought to lower drug prices in California as part of a broader focus on health care costs, an approach he may bring to a new role in the Biden Administration.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.